0001104659-20-079120.txt : 20200630 0001104659-20-079120.hdr.sgml : 20200630 20200630173553 ACCESSION NUMBER: 0001104659-20-079120 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200626 FILED AS OF DATE: 20200630 DATE AS OF CHANGE: 20200630 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Simons Emmanuel CENTRAL INDEX KEY: 0001815162 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39343 FILM NUMBER: 201003256 MAIL ADDRESS: STREET 1: C/O AKOUOS, INC. STREET 2: 645 SUMMER STREET SUITE 200 CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akouos, Inc. CENTRAL INDEX KEY: 0001722271 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 645 SUMMER STREET, SUITE 200 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 857-245-5715 MAIL ADDRESS: STREET 1: 645 SUMMER STREET, SUITE 200 CITY: BOSTON STATE: MA ZIP: 02210 4 1 a4.xml 4 X0306 4 2020-06-26 0 0001722271 Akouos, Inc. AKUS 0001815162 Simons Emmanuel C/O AKOUOS, INC. 645 SUMMER STREET SUITE 200 BOSTON MA 02210 1 1 1 0 President and CEO Common Stock 2020-06-26 4 C 0 35312 A 35312 D Series Seed-1 Preferred Stock 2020-06-30 4 C 0 35312 0.00 D Common Stock 35312 0 D Stock Option (right to buy) 17.00 2020-06-26 4 A 0 838066 0.00 A 2030-06-17 Common Stock 838066 838066 D On June 30, 2020, the Series Seed-1 Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series Seed-1 Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. The option was granted on June 18, 2020, effective as of and contingent upon the commencement of trading of the Issuer's shares of common stock on the Nasdaq Global Select Market, which occurred on June 26, 2020. The shares underlying the option vest over four years in equal monthly installments from June 18, 2020 through June 18, 2024. /s/ Karoline K. Shair, Attorney-in-Fact For Emmanuel Simons 2020-06-30